Back
Replimune Group Vs. Bristol-Myers Squibb Industry Stock Comparison
Sell
47
REPL
Replimune Group
Last Price:
14.40
Seasonality Move:
-14.22%
Buy
58
BMY
Bristol-Myers Squibb
Last Price:
58.73
Seasonality Move:
1.42%
Sell
47
Replimune Group (REPL)
is a Sell
Is Replimune Group a Buy, Sell or Hold?
- The current Replimune Group [REPL] share price is $13.26. The Score for REPL is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- REPL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Bristol-Myers Squibb (BMY)
is a Buy
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $58.78. The Score for BMY is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- BMY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
REPL Stock Price Chart
What is Replimune Group's stock price today?
-
The Replimune Group share price today is $13.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REPL is experiencing selling pressure, which indicates risk of future bearish movement.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $58.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing selling pressure, which indicates risk of future bearish movement.
REPL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 58.49 | Buy |
| Chaikin Money Flow: | -1589558 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.16 - 12.84) | Buy |
| Bollinger Bands (100): | (9.81 - 11.89) | Buy |
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.48 | Buy |
| Relative Strength Index (14 RSI): | 62.13 | Buy |
| Chaikin Money Flow: | -11877272 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.31 - 58.27) | Buy |
| Bollinger Bands (100): | (45.42 - 54.94) | Buy |
REPL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.8 | Buy |
| 20-day SMA: | 12.01 | Buy |
| 50-day SMA: | 11.63 | Buy |
| 200-day SMA: | 9.16 | Buy |
| 8-day EMA: | 12.35 | Buy |
| 20-day EMA: | 12 | Buy |
| 50-day EMA: | 11.55 | Buy |
| 200-day EMA: | 10.64 | Buy |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.94 | Buy |
| 20-day SMA: | 56.58 | Buy |
| 50-day SMA: | 53.77 | Buy |
| 200-day SMA: | 48.56 | Buy |
| 8-day EMA: | 58.07 | Buy |
| 20-day EMA: | 56.73 | Buy |
| 50-day EMA: | 54.15 | Buy |
| 200-day EMA: | 50.88 | Buy |
Replimune Group Earnings Growth & REPL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.35 per share, and an increase next year of $0.52 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.48 per share, and an increase next year of $6.15 per share.
Replimune Group Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bristol-Myers Squibb Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||